Tripropeptin C blocks the lipid cycle of cell wall biosynthesis by complex formation with undecaprenyl pyrophosphate

Hideki Hashizume1, Ryuichi Sawa, Shigeko Harada

  • 1Drug Development Unit, Bioactive Molecule Research Group, Laboratory of Disease Biology, Institute of Microbial Chemistry, Tokyo, Japan. hashizumeh@bikaken.or.jp

Insights

Tripropeptin C (TPPC) is a novel cyclic lipodepsipeptide antibiotic effective against resistant bacteria like MRSA. It disrupts bacterial cell wall synthesis by inhibiting undecaprenyl pyrophosphate dephosphorylation and potentially other key steps.

Area of Science:

  • Microbiology
  • Biochemistry
  • Drug Discovery

Background:

  • Antibiotic resistance is a growing global health threat, necessitating the discovery of new antimicrobial agents.
  • Naturally occurring compounds offer a promising source for novel antibiotics with unique mechanisms of action.
  • Methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and penicillin-resistant Streptococcus pneumoniae are critical pathogens with limited treatment options.

Purpose of the Study:

  • To investigate the antibacterial activity and mechanism of action of Tripropeptin C (TPPC), a cyclic lipodepsipeptide antibiotic.
  • To elucidate the specific molecular targets and pathways inhibited by TPPC in bacterial pathogens.
  • To compare the mode of action of TPPC with existing antibiotics.

Main Methods:

  • Antibacterial susceptibility testing against resistant bacterial strains (MRSA, VRE, S. pneumoniae).
  • Enzyme inhibition assays to determine the IC(50) for peptidoglycan synthesis and C(55)-PP phosphatase activity.
  • Cellular accumulation studies using mass spectrometry and thin-layer chromatography to analyze metabolic intermediates.
  • In vitro biochemical assays to assess interactions with undecaprenyl pyrophosphate (C(55)-PP).

Main Results:

  • TPPC demonstrated potent activity against MRSA, VRE, and penicillin-resistant S. pneumoniae.
  • TPPC inhibited N-acetylglucosamine incorporation into peptidoglycan and caused cytoplasmic accumulation of UDP-MurNAc-pentapeptide.
  • TPPC directly interacted with C(55)-PP, inhibiting C(55)-PP phosphatase activity with an IC(50) of 0.03–0.1 μM.
  • TPPC treatment led to C(55)-PP accumulation and inhibition of transglycosylation or flippase activity.

Conclusions:

  • TPPC represents a novel class of antibiotics targeting bacterial cell wall synthesis through a unique multi-step inhibition mechanism.
  • Its distinct mode of action, involving C(55)-PP phosphatase inhibition and potential downstream effects, differentiates it from current antibiotics.
  • TPPC holds potential as a therapeutic agent against multidrug-resistant bacterial infections.

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Peptidoglycan Synthesis01:28

Peptidoglycan Synthesis

Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan biosynthesis begins in...
Biosynthesis of Lipids01:29

Biosynthesis of Lipids

Microbial membranes exhibit remarkable diversity in lipid composition, reflecting evolutionary adaptations to various environmental conditions. The three domains of life—Bacteria, Archaea, and Eukarya—synthesize membrane lipids through distinct biosynthetic pathways, leading to fundamental structural differences that impact membrane stability, function, and adaptability.Fatty Acid-Based Lipids in Bacteria and EukaryaBacteria and eukaryotes share a common fatty acid biosynthesis pathway, which...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...